The findings identify specific receptors for the neurotransmitter acetylcholine that re-route information flowing through memory circuits in the hippocampus.
Bristol-led research has identified specific drug targets within the neural circuits that encode memories, paving the way for significant advances in the treatment of a broad spectrum of brain disorders.
Loss of memory is a core feature of many neurological and psychiatric disorders including Alzheimer’s disease and schizophrenia. Current treatment options for memory loss are very limited and the search for safe and effective drug therapies has, until now, had limited success.
The research was done in collaboration with colleagues at the international biopharmaceutical company Sosei Heptares. The findings, published in Nature Communications, identify specific receptors for the neurotransmitter acetylcholine that re-route information flowing through memory circuits in the hippocampus. Acetylcholine is released in the brain during learning and is critical for the acquisition of new memories. Until now, the only effective treatment for the symptoms of cognitive or memory impairment seen in diseases such as Alzheimer’s is using drugs that broadly boost acetylcholine. However, this leads to multiple adverse side effects. The discovery of specific receptor targets that have the potential to provide the positive effects whilst avoiding the negative ones is promising.
Lead author, Professor Jack Mellor, from the University of Bristol’s Centre for Synaptic Plasticity, said: “These findings are about the fundamental processes that occur in the brain during the encoding of memory and how they may be regulated by brain state or drugs targeting specific receptor proteins. In the long-term, the discovery of these specific targets opens up avenues and opportunities for the development of new treatments for the symptoms of Alzheimer’s disease and other conditions with prominent cognitive impairments. The academic-industry partnership is important for these discoveries and we hope to continue working together on these projects.”
Dr Miles Congreve, Chief Scientific Officer at Sosei Heptares, added: “These important studies have helped us to design and select new, exquisitely targeted therapeutic agents that mimic the effects of acetylcholine at specific muscarinic receptors, without triggering the unwanted side effects of earlier and less-well targeted treatments. This approach has the exciting potential to improve memory and cognitive function in patients with Alzheimer’s and other neurological diseases.”
“It is fascinating how the brain prioritises different bits of information, working out what is important to encode in memory and what can be discarded. We know there must be mechanisms to pull out the things that are important to us but we know very little about how these processes work. Our future programme of work aims to reveal how the brain does this using acetylcholine in tandem with other neurotransmitters such as dopamine, serotonin and noradrenaline,” said Professor Mellor.
Original Article: Research reveals drug targets for memory enhancement
More from: University of Bristol
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Memory loss treatment
- Lung cancer fundraising in memory of James Brokenshire hits £25,000on October 12, 2021 at 3:18 am
The Roy Castle Lung Cancer Foundation has praised the “wonderful generosity” of supporters, after raising over £25,000 in four days in memory of the politician James Brokenshire. Brokenshire was a ...
- Search On For Family Of Man With Memory Loss Found In North Sacramentoon October 11, 2021 at 1:33 pm
Authorities are asking for help in finding the family of an elderly man with apparent memory issues who was found in North.
- 'He's going to carry me on his wings': Man running Boston Marathon in late son's memoryon October 11, 2021 at 9:17 am
The 62-year-old is tackling the grueling 26.2 miles for his son, Joey, who was diagnosed with astrocytoma. Joey died in 2000 when he was 3 years old.
- Hepatic Encephalopathy Treatment Market is rising…on October 9, 2021 at 12:15 am
Global hepatic encephalopathy treatment market is rising gradually with a substantial CAGR of 5.4% in the forecast period of 2020-2027. The report contains data of the base year 2019 and historic year ...
- Presynaptic mitochondrial morphology in monkey prefrontal cortex correlates with working memory and is improved with estrogen treatmenton October 6, 2021 at 2:17 pm
Human and nonhuman primates are vulnerable to age- and menopause-related decline in working memory, a cognitive function reliant on the energy-demanding excitation of prefrontal cortex (PFC) neurons.
Go deeper with Google Headlines on:
Memory loss treatment
Go deeper with Bing News on:
- Study finds certain drug targets for memory enhancementon October 6, 2021 at 6:52 am
The findings identify specific receptors for the neurotransmitter acetylcholine that re-route information flowing through memory circuits in the hippocampus. Acetylcholine is released in the brain ...
- Beta-amyloid-related peptides inhibit potassium-evoked acetylcholine release from rat hippocampal sliceson October 6, 2021 at 3:49 am
The 4 kDa beta-amyloid (A beta) protein, a major component of cerebral and cerebrovascular plaques in Alzheimer's disease (AD), is derived from the proteolytic cleavage of a larger, membrane-bound ...
- State-dependent release of acetylcholine in rat thalamus measured by in vivo microdialysison October 5, 2021 at 1:32 pm
Mesopontine cholinergic neurons have long been thought to play a key role in behavioral state control. In particular, they have been implicated in the process of EEG desynchrony and in the generation ...
- The Asthma–Chronic Obstructive Pulmonary Disease Overlap Syndromeon October 4, 2021 at 5:00 pm
Newer treatments such as varenicline target α 4, β 2-nicotinic acetylcholine receptors in the mesolimbic nervous system and thereby block nicotine from binding to these receptors. The nicotine ...
- Get the Brain Boost You Need With an Advanced Acetylcholine Supplementon October 1, 2021 at 3:51 pm
Even if you’ve never heard of acetylcholine before, you’ve still got it on your mind… literally. That’s because it’s a neurotransmitter that your brain needs to perform vital functions ...